Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.
about
Associations of World Trade Center exposures with pulmonary and cardiometabolic outcomes among children seeking care for health concernsNonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementComorbidities and Metabolic Derangement of NAFLDNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayReview of nonalcoholic fatty liver disease in women with polycystic ovary syndromeRole of cytokines and chemokines in non-alcoholic fatty liver diseaseClinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsSexually dimorphic genome-wide binding of retinoid X receptor alpha (RXRα) determines male-female differences in the expression of hepatic lipid processing genes in miceRecommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisAssociation between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort studySerum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver DiseaseEthnic differences in the link between insulin resistance and elevated ALT.Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study.Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescentsFatty liver disease in children: eat now pay later.Gender difference of alanine aminotransferase elevation may be associated with higher hemoglobin levels among male adolescents.Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children.Changes in ponderal index and body mass index across childhood and their associations with fat mass and cardiovascular risk factors at age 15.Pediatric Non-Alcoholic Fatty Liver DiseaseIdentification and treatment of metabolic complications in pediatric obesity.Predicting hepatic steatosis in a racially and ethnically diverse cohort of adolescent girls.Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.Liver resection and metabolic disorders: an undescribed mechanism leading to postoperative mortality.Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal childrenEthnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetesSuspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesityAminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.Non-alcoholic fatty liver disease in children: focus on nutritional interventions.Improved insulin sensitivity and body composition, irrespective of macronutrient intake, after a 12 month intervention in adolescents with pre-diabetes; RESIST a randomised control trialPediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.The metabolic syndrome and nonalcoholic fatty liver disease in childrenCentral obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys.Update on fatty liver disease and steatohepatitis.6-gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism.Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants.
P2860
Q23916859-4877CAF4-B6E6-459F-A74E-67BDD13D6E56Q24649618-B0C93FF0-3934-4C83-BE5A-69BE96711CA2Q26777147-3B3DAFCE-7C17-4EB1-82CA-811F32A16707Q26800894-6D63839C-9FEB-424A-A2FE-AD0C154C52B8Q26828765-C72392B6-0ABB-485F-8D4B-BDBC60CFA896Q26830328-0BFABEBF-3367-4AA0-8EFB-790F7B5D7E72Q26859406-140E2ADF-62A4-4C5B-AFE5-3B32CD1D077FQ28386598-0F3F45D9-B583-4891-A11C-BD004376BA8FQ28535445-DAC3479B-E332-43D8-AB2B-FF871372A089Q28607750-7D80BDE7-6205-471F-A9EF-703D1BB0AE03Q28748155-6604EE54-65D9-42FE-9308-3A345E3482CCQ30252383-A0DE4892-1E40-4D13-B50D-32BBAB64A2CAQ30367203-213DAEE8-CCD4-4E64-9F27-5730584C43C4Q30411106-415BFD1A-9E76-47C7-B3B3-00FDAE0C9216Q30431928-86B450DB-0919-4DD2-AAB6-E42BF565DA85Q30440631-2B9B01CF-39F4-4CC1-ABD6-8908E442657BQ33718945-6C0005E8-0F0F-46A1-8450-356C821BC208Q33725657-8F40BC8C-743D-4F1B-9C1E-60BFDE62B97AQ33748493-A679CC5E-39D8-4639-B7B2-2FF1D5279178Q33775645-C8574AAC-F6F6-4702-85E6-B66AF59583B5Q33831717-705F2D2D-FF78-4E2B-A122-3B5137BCBA6EQ33893011-04BC06E5-1CF8-40E3-A235-B15BF730AA1EQ34040931-9528FDCF-2060-4D49-85DA-824E99C29D48Q34090872-9EA3C36E-B826-4816-8A3D-81E8A6D3836BQ34114795-4126ED65-FA6E-4588-B06F-6D9F8E5CD065Q34366984-93968EF9-7C51-48D6-85F1-57C1A8BD8695Q34404169-67B1DC80-9C54-47B7-AE46-ABA49C1F86E4Q34470507-6DFE2013-5F7A-49C6-A5B5-698DFE4E7EFAQ34572659-3D51373D-4669-4704-AAA6-8A0915125D80Q34574104-26394886-001E-41C6-A37A-1B6C77839F71Q34577949-9067AB5A-84AE-468A-B621-01A1F9CC2BB6Q34611963-C2CE3338-50E0-4E41-9AEB-64B2FFF54D49Q34636684-3E1B2620-88A7-4F93-83FF-0328E9CA99D7Q34758939-595825C2-32C7-4C2D-9A93-8479039E3430Q34778237-F0A5E22E-A1DD-405B-A594-D71FF74E66F0Q35045813-AE45468D-38C7-4EDE-8138-11C70EA28014Q35047420-23073703-CFD4-4EFD-8822-5DF7574424AAQ35119509-0DC7FE20-17A3-4A9C-979D-50C2AEBC7BD8Q35131341-97A01B4C-B776-4A53-BF5E-97FE3AB7201DQ35535285-442823C7-3BF2-49A8-80EC-34C733C3F2A9
P2860
Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@ast
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@en
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@en-gb
type
label
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@ast
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@en
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@en-gb
prefLabel
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@ast
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@en
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@en-gb
P2860
P50
P1433
P1476
Prevalence of elevated alanine ...... ted factors: NHANES 1999-2004.
@en
P2860
P304
P356
10.1053/J.GASTRO.2007.08.077
P407
P577
2007-09-02T00:00:00Z